Bruce Gerhardt - 16 Jul 2021 Form 4 Insider Report for BIOCEPT INC

Role
Director
Signature
/s/ Michael W. Nall, Attorney-in-fact
Issuer symbol
N/A
Transactions as of
16 Jul 2021
Net transactions value
$0
Form type
4
Filing time
20 Jul 2021, 16:46:18 UTC
Next filing
08 Sep 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BIOC Employee Stock Option (right to buy) Award $0 +10,000 $0.000000 10,000 16 Jul 2021 Common Stock 10,000 $3.77 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares subject to the option shall be 100% vested and exercisable on July 16, 2022.